Household transmission of the SARS-CoV-2 omicron variant in New Zealand, 2022

被引:0
作者
Aminisani, Nayyereh [1 ]
Huang, Q. Sue [1 ]
Jelley, Lauren [1 ,2 ,3 ]
Wood, Timothy [1 ]
Jennings, Tineke [4 ]
Currin, Danielle [1 ]
Seeds, Ruth [1 ]
Marull, Maritza [1 ]
Kvalsvig, Amanda [2 ,3 ]
Baker, Michael G. [2 ,3 ]
Nghiem, Nhung [2 ,3 ]
Thomas, Paul G. [5 ]
Webby, Richard J. [5 ]
机构
[1] Inst Environm Sci & Res, Wellington, New Zealand
[2] Univ Otago, Wellington, New Zealand
[3] Univ Otago, Dunedin, New Zealand
[4] Te Whatu Ora Hlth New Zealand Capital Coast & Hutt, Reg Publ Hlth, Wellington, New Zealand
[5] St Jude Childrens Res Hosp, World Hlth Org Collaborating Ctr Influenza, Memphis, TN USA
来源
VACCINE: X | 2025年 / 24卷
关键词
SARS-CoV-2 omicron variant; Household transmission; Secondary attack rate; Serial interval; COVID-19;
D O I
10.1016/j.jvacx.2025.100638
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Studying the transmissibility of the SARS-CoV-2 and its driving factors is valuable due to the ongoing emergence of new variants. We examined the household transmission characteristics of the Omicron-dominant variant. Methods: The study took place in Wellington, New Zealand, from 7-February to 2-October 2022. When an individual had a confirmed case of SARS-CoV-2, all household members were instructed to take a swab every 3rd day until two consecutive negative swabs were obtained from the last person with SARS-CoV-2. Participants were monitored daily for acute respiratory symptoms until no further symptoms. Results: We enrolled 75 households with confirmed cases of SARS-CoV-2 (total enrolled individuals = 306). The median serial interval was 4 days, and the secondary attack rate (SAR) was 60.6 % (95 % confidence interval (CI) 54.1-66.7). The SAR was higher for older household contacts and lower for contacts of fully vaccinated index cases. The SAR was highest when both the index case and the contacts were unvaccinated or received only one vaccine dose (88 %). Conclusions: In this household cohort, the SARS-CoV-2 Omicron variant showed a high SAR which was modifiable by vaccination; the vaccination status of the index case and household members significantly reduced this.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Challenges of SARS-CoV-2 Omicron Variant and appropriate countermeasures
    Shao, Wenxia
    Zhang, Weiying
    Fang, Xiang
    Yu, Daojun
    Wang, Xianjun
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2022, 55 (03) : 387 - 394
  • [32] Epidemiological, clinical, and household transmission characteristics of children and adolescents infected with SARS-CoV-2 Omicron variant in Shanghai, China: a retrospective, multicenter observational study
    Liu, Yazun
    Xu, Lan
    Piao, Xiang
    Li, Han
    Shi, Li
    Huang, Yue
    Zhou, Huan
    Yang, Yan
    Liu, Xiao
    Wu, Mingyun
    He, Yuanyuan
    Yin, Yong
    Wang, Libo
    Yu, Jian
    Zhou, Wenhao
    Zheng, Junhua
    Zhong, Victor W.
    Xue, Zheng
    Zhong, Liwei
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 129 : 1 - 9
  • [33] SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household
    Yi, Seonju
    Kim, Jong Mu
    Choe, Young June
    Hong, Sujin
    Choi, Siwon
    Ahn, Seong Bae
    Kim, Miya
    Park, Young-Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (01)
  • [34] Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy
    Joshi, Gaurav
    Poduri, Ramarao
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [35] SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023
    Mengyan Zhang
    Lei Cao
    Luqian Zhang
    Xinxin Li
    Sa Chen
    Yi Zhang
    BMC Public Health, 24
  • [36] SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023
    Zhang, Mengyan
    Cao, Lei
    Zhang, Luqian
    Li, Xinxin
    Chen, Sa
    Zhang, Yi
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [37] Modelling the dynamics of infection, waning of immunity and re-infection with the Omicron variant of SARS-CoV-2 in Aotearoa New Zealand
    Vattiatio, Giorgia
    Lustig, Audrey
    Maclaren, Oliver J.
    Plank, Michael J.
    EPIDEMICS, 2022, 41
  • [38] Across-the-board review on Omicron SARS-CoV-2 variant
    Wasim, Rufaida
    Sumaiya, Asad
    Ahmad, Asad
    INFLAMMOPHARMACOLOGY, 2025, 33 (01) : 1 - 10
  • [39] Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
    Chavda, Vivek P.
    Balar, Pankti
    Vaghela, Dixa
    Solanki, Hetvi K.
    Vaishnav, Akta
    Hala, Vivek
    Vora, Lalitkumar
    VACCINES, 2023, 11 (01)
  • [40] Outpatient treatment options to address the SARS-CoV-2 variant Omicron
    McCarthy, Matthew W.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (08) : 1129 - 1133